Zobrazeno 1 - 10
of 29
pro vyhledávání: '"JV Matous"'
Autor:
S D'Sa, JV Matous, R Advani, C Buske, JJ Castillo, M Gatt, P Kapoor, MJ Kersten, V Leblond, M Leiba, ML Palomba, J Paludo, L Qiu, S Sarosiek, M Shadman, D Talaulikar, CS Tam, A Tedeschi, SK Thomas, I Tohidi-Esfahani, J Trotman, M Varettoni, JMI Vos, R Garcia-Sanz, J San-Miguel, MA Dimopoulos, SP Treon, E Kastritis
Publikováno v:
Seminars in hematology. W.B. Saunders Ltd
The consensus panel 2 (CP2) of the 11th International Workshop on Waldenström's macroglobulinemia (IWWM-11) has reviewed and incorporated current data to update the recommendations for treatment approaches in patients with relapsed or refractory WM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4646fcb4e979b506ad03466c79f2863
https://pure.amc.nl/en/publications/report-of-consensus-panel-2-from-the-11th-international-workshop-on-waldenstroems-macroglobulinemia-on-the-management-of-relapsed-or-refractory-wm-patients(6395fe8f-43ea-44e8-8c1a-86b26327e3da).html
https://pure.amc.nl/en/publications/report-of-consensus-panel-2-from-the-11th-international-workshop-on-waldenstroems-macroglobulinemia-on-the-management-of-relapsed-or-refractory-wm-patients(6395fe8f-43ea-44e8-8c1a-86b26327e3da).html
Autor:
Delimpasi S; Department of Hematology and Bone Marrow Transplantation Unit, General Hospital Evangelismos, Athens, Greece., Dimopoulos MA; Hematology & Medical Oncology, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece., Straub J; Department of Internal Medicine - Hematology, University Hospital, Prague, Czech Republic., Symeonidis A; Department of Hematology, University General Hospital of Patras, Patras, Greece., Pour L; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic., Hájek R; Department of Haematooncology, University Hospital Ostrava and Department of Haematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Touzeau C; University Hospital Hôtel Dieu, Nantes, France., Bhanderi VK; Florida Cancer Specialists, Tallahassee Cancer Center, Tallahassee, Florida, USA., Berdeja JG; Sarah Cannon Research Institute, Nashville, Tennessee, USA., Pavlíček P; Department of Internal Medicine and Hematology, University Hospital Kralovske Vinohrady, Prague, Czech Republic., Matous JV; Colorado Blood Cancer Institute and Sarah Cannon Research Institute, Denver, Colorado, USA., Robak PJ; Department of Hematology, Medical University of Lodz and Copernicus Memorial Hospital, Lodz, Poland., Suryanarayan K; Clinical Research, Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts, USA., Miller A; Statistics, Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts, USA., Villarreal M; Oncology, Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts, USA., Cherepanov D; Global Evidence and Outcomes (GEO), Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts, USA., Srimani JK; Quantitative Clinical Pharmacology, Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts, USA., Yao H; Precision and Translational Medicine, Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts, USA., Labotka R; Oncology Clinical Research, Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts, USA., Orlowski RZ; Departments of Lymphoma/Myeloma and Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
American journal of hematology [Am J Hematol] 2024 Sep; Vol. 99 (9), pp. 1746-1756. Date of Electronic Publication: 2024 Jun 10.
Autor:
Mailankody S; Myeloma Service and Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA. mailanks@mskcc.org.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. mailanks@mskcc.org., Matous JV; Colorado Blood Cancer Institute, Denver, CO, USA., Chhabra S; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA., Liedtke M; Division of Hematology, Department of Medicine, Stanford University, Stanford, CA, USA., Sidana S; Division of Bone Marrow Transplantation and Cellular Therapy, Stanford University Hospital, Stanford, CA, USA., Oluwole OO; Vanderbilt University Medical Center, Nashville, TN, USA., Malik S; Bone Marrow Transplant and Cellular Therapy Program, Sarah Cannon Blood Cancer Center at St. David's South Austin Medical Center, Austin, TX, USA., Nath R; Banner MD Anderson Cancer Center, Gilbert, AZ, USA., Anwer F; Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, USA., Cruz JC; Texas Transplant Institute, San Antonio, TX, USA., Htut M; Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA, USA., Karski EE; Allogene Therapeutics, South San Francisco, CA, USA., Lovelace W; Allogene Therapeutics, South San Francisco, CA, USA., Dillon M; Allogene Therapeutics, South San Francisco, CA, USA., Butz E; Allogene Therapeutics, South San Francisco, CA, USA., Ying W; Allogene Therapeutics, South San Francisco, CA, USA., Balakumaran A; Allogene Therapeutics, South San Francisco, CA, USA., Kumar SK; Mayo Clinic, Rochester, MN, USA.
Publikováno v:
Nature medicine [Nat Med] 2023 Dec; Vol. 29 (12), pp. 3271.
Autor:
Varettoni M; Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Via Golgi 19, 27100 Pavia, Italy. Electronic address: m.varettoni@smatteo.pv.it., Matous JV; Colorado Blood Cancer Institute, Sarah Cannon Research Institute, Denver, CO, USA.
Publikováno v:
Hematology/oncology clinics of North America [Hematol Oncol Clin North Am] 2023 Aug; Vol. 37 (4), pp. 707-717. Date of Electronic Publication: 2023 May 26.
Autor:
D'Sa S; UCLH Centre for Waldenström Macroglobulinaemia and Related Conditions, University College London Hospitals NHS Foundation Trust, London, UK. Electronic address: s.d.sa@nhs.net., Matous JV; Colorado Blood Cancer Institute, Sarah Cannon Research Institute, Denver, CO., Advani R; Stanford University Medical Center, Stanford, CA., Buske C; University Hospital Ulm, Ulm, Germany., Castillo JJ; Dana Farber Cancer Institute, Harvard Medical School, Boston, MA., Gatt M; Hadassah University Medical Center, Jerusalem, Israel., Kapoor P; Mayo Clinic, Rochester, MN, USA., Kersten MJ; Amsterdam UMC, University of Amsterdam, Department of Hematology, Cancer Center Amsterdam/LYMMCARE, Amsterdam, Netherlands., Leblond V; Groupe Hospitalier Pitié-Salpêtrière, Sorbonne University, Paris, France., Leiba M; Assuta Ashdod University Hospital; Faculty of Health Science, Ben-Gurion University of the Negev, Negev, Israel Memorial Sloan Kettering Cancer Center, New York, NY., Palomba ML; Memorial Sloan Kettering Cancer Center, New York NY US., Paludo J; Mayo Clinic, Rochester, MN, USA., Qiu L; National Clinical Medical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China., Sarosiek S; Dana Farber Cancer Institute, Harvard Medical School, Boston, MA., Shadman M; Fred Hutchinson Cancer Center., Talaulikar D; ANU College of Health and Medicine, Canberra, Australia., Tam CS; Alfred Health, Monash University, Melbourne, Australia., Tedeschi A; A. O. Ospedale Niguarda Ca' Granda, Milan, Italy., Thomas SK; University of Texas, MD Anderson Cancer Center, Houston TX USA., Tohidi-Esfahani I; Concord Repatriation General Hospital, University of Sydney, Sydney, Australia., Trotman J; Concord Repatriation General Hospital, University of Sydney, Sydney, Australia., Varettoni M; Division of Hematology, Fondazione iRCCS Policlinico, San Matteo, Italy., Vos J; Amsterdam UMC, University of Amsterdam, Department of Hematology, Cancer Center Amsterdam/LYMMCARE, Amsterdam, Netherlands., Garcia-Sanz R; Hematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca, CIBERONC and Center for Cancer Research-IBMCC (University of Salamanca-CSIC), Salamanca, Spain., San-Miguel J; Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, Centro de Investigación Biomédica en Red Cáncer, Pamplona, Spain., Dimopoulos MA; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece., Treon SP; Dana Farber Cancer Institute, Harvard Medical School, Boston, MA., Kastritis E; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
Publikováno v:
Seminars in hematology [Semin Hematol] 2023 Mar; Vol. 60 (2), pp. 80-89. Date of Electronic Publication: 2023 Mar 27.
Autor:
Buske C; University Hospital Ulm, Institute of Experimental Cancer Research, Ulm, Germany. Electronic address: christian.buske@uni-ulm.de., Castillo JJ; Dana Farber Cancer Institute, Harvard Medical School, Boston MA., Abeykoon JP; Mayo Clinic, Rochester MN., Advani R; Stanford University Medical Center, Stanford CA., Arulogun SO; University College London Hospitals, London UK., Branagan AR; Massachusetts General Hospital, Boston MA., Cao X; Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., D'Sa S; University College London Hospitals, London UK., Hou J; Renji Hospital, Shanghai China., Kapoor P; Mayo Clinic, Rochester MN., Kastritis E; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece., Kersten MJ; Department of Hematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam/LYMMCARE, Amsterdam, Netherlands., LeBlond V; Groupe Hospitalier Pitié-Salpêtrière, Sorbonne University, Paris France., Leiba M; Faculty of Health Science, Ben- Gurion University of the Negev, Israel Assuta Ashdod University Hospital; Faculty of Health Science, Ben-Gurion University of the Negev, Negev, Israel Memorial Sloan Kettering Cancer Center, New York, NY., Matous JV; Colorado Blood Cancer Institute, Sarah Cannon Research Institute, Denver, CO., Paludo J; Mayo Clinic, Rochester MN., Qiu L; National Clinical Medical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China., Tam CS; Alfred Health, Monash University, Melbourne, Australia., Tedeschi A; A.O. Ospedale Niguarda Ca' Granda, Milan, Italy., Thomas SK; University of Texas, MD Anderson Cancer Center, Houston, TX., Tohidi-Esfahani I; Concord Repatriation General Hospital, University of Sydney, Sydney, Australia., Varettoni M; Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Vos JM; Department of Hematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam/LYMMCARE, Amsterdam, Netherlands., Garcia-Sanz R; Hematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca, CIBERONC and Center for Cancer Research-IBMCC (University of Salamanca-CSIC), Salamanca, Spain., San-Miguel J; Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, Centro de Investigación Biomédica en Red Cáncer, Pamplona, Spain., Dimopoulos MA; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece., Treon SP; Dana Farber Cancer Institute, Harvard Medical School, Boston MA., Trotman J; Concord Repatriation General Hospital, University of Sydney, Sydney, Australia.
Publikováno v:
Seminars in hematology [Semin Hematol] 2023 Mar; Vol. 60 (2), pp. 73-79. Date of Electronic Publication: 2023 Mar 29.
Autor:
Mailankody S; Myeloma Service and Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA. mailanks@mskcc.org.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. mailanks@mskcc.org., Matous JV; Colorado Blood Cancer Institute, Denver, CO, USA., Chhabra S; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA., Liedtke M; Division of Hematology, Department of Medicine, Stanford University, Stanford, CA, USA., Sidana S; Division of Bone Marrow Transplantation and Cellular Therapy, Stanford University Hospital, Stanford, CA, USA., Oluwole OO; Vanderbilt University Medical Center, Nashville, TN, USA., Malik S; Bone Marrow Transplant and Cellular Therapy Program, Sarah Cannon Blood Cancer Center at St. David's South Austin Medical Center, Austin, TX, USA., Nath R; Banner MD Anderson Cancer Center, Gilbert, AZ, USA., Anwer F; Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, USA., Cruz JC; Texas Transplant Institute, San Antonio, TX, USA., Htut M; Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA, USA., Karski EE; Allogene Therapeutics, South San Francisco, CA, USA., Lovelace W; Allogene Therapeutics, South San Francisco, CA, USA., Dillon M; Allogene Therapeutics, South San Francisco, CA, USA., Butz E; Allogene Therapeutics, South San Francisco, CA, USA., Ying W; Allogene Therapeutics, South San Francisco, CA, USA., Balakumaran A; Allogene Therapeutics, South San Francisco, CA, USA., Kumar SK; Mayo Clinic, Rochester, MN, USA.
Publikováno v:
Nature medicine [Nat Med] 2023 Feb; Vol. 29 (2), pp. 422-429. Date of Electronic Publication: 2023 Jan 23.
Autor:
Buske C; Institute of Experimental Cancer Research, Comprehensive Cancer Center Ulm, University Hospital of Ulm, Ulm, Germany., Tedeschi A; ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy., Trotman J; Concord Hospital, University of Sydney, Sydney, Australia., García-Sanz R; Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), Salamanca, Spain., MacDonald D; The Ottawa Hospital, University of Ottawa, Ottawa, Canada., Leblond V; Département d'Hématologie Hôpital Pitié-Salpêtrière AP-HP, Sorbonne Université, Paris, France., Mahe B; Centre Hospitalier Universitaire de Nantes, Nantes, France., Herbaux C; Centre Hospitalier Régional Universitaire de Lille, Institute of Hematology-Transfusion, Lille, France., Matous JV; Colorado Blood Cancer Institute, Denver, CO., Tam CS; Peter MacCallum Cancer Centre & St Vincent's Hospital and the University of Melbourne, Melbourne, Australia., Heffner LT; Winship Cancer Institute of Emory University, Atlanta, GA., Varettoni M; Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Palomba ML; Memorial Sloan Kettering Cancer Center, New York, NY., Shustik C; Royal Victoria Hospital at McGill University Health Centre, Montreal, Canada., Kastritis E; National and Kapodistrian University of Athens School of Medicine, Athens, Greece., Treon SP; Dana-Farber Cancer Institute, Boston, MA., Ping J; Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA., Hauns B; Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA., Arango-Hisijara I; Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA., Dimopoulos MA; National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Jan 01; Vol. 40 (1), pp. 52-62. Date of Electronic Publication: 2021 Oct 04.
Autor:
Trotman J; Concord Hospital, University of Sydney, Concord, New South Wales, Australia. judith.trotman@health.nsw.gov.au., Buske C; Comprehensive Cancer Center Ulm and Institute of Experimental Cancer Research, University Hospital of Ulm, Ulm, Germany., Tedeschi A; ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy., Matous JV; Colorado Blood Cancer Institute, Denver, Colorado., MacDonald D; The Ottawa Hospital, University of Ottawa, Ottawa, Ontario, Canada., Tam CS; St. Vincent's Hospital, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia., Tournilhac O; Hématologie Clinique Adulte et Thérapie Cellulaire, CHU Hotel Dieu Hématologie, Clermont-Ferrand, France., Ma S; Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois., Treon SP; Dana-Farber Cancer Institute, Boston, Massachusetts., Oriol A; Institut Català d'Oncologia, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain., Ping J; Pharmacyclics LLC, an AbbVie Company, Sunnyvale, California., Briso EM; Pharmacyclics Switzerland GmbH, an AbbVie Company, Schaffhausen, Switzerland., Arango-Hisijara I; Pharmacyclics LLC, an AbbVie Company, Sunnyvale, California., Dimopoulos MA; National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Nov 01; Vol. 27 (21), pp. 5793-5800. Date of Electronic Publication: 2021 Aug 11.
Autor:
Berdeja JG; Sarah Cannon Research Institute, Nashville, Tennessee.; Tennessee Oncology PLLC, Nashville, Tennessee., Gregory TK; Sarah Cannon Research Institute, Nashville, Tennessee.; Colorado Blood Cancer Institute, Denver, Colorado., Faber EA; Sarah Cannon Research Institute, Nashville, Tennessee.; Oncology Hematology Care, Cincinnati, Ohio., Hart LL; Sarah Cannon Research Institute, Nashville, Tennessee.; Florida Cancer Specialists, Fort Myers, Florida., Mace JR; Sarah Cannon Research Institute, Nashville, Tennessee.; Florida Cancer Specialists, St. Petersburg, Florida., Arrowsmith ER; Sarah Cannon Research Institute, Nashville, Tennessee.; Tennessee Oncology PLLC, Chattanooga, Tennessee., Flinn IW; Sarah Cannon Research Institute, Nashville, Tennessee.; Tennessee Oncology PLLC, Nashville, Tennessee., Matous JV; Sarah Cannon Research Institute, Nashville, Tennessee.; Colorado Blood Cancer Institute, Denver, Colorado.
Publikováno v:
American journal of hematology [Am J Hematol] 2021 Apr 01; Vol. 96 (4), pp. 428-435. Date of Electronic Publication: 2021 Jan 28.